Income Statement

ARCTURUS THERAPEUTICS HOLDINGS INC.

ARCT
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Revenue
82.03 152.31 166.80 206.00 12.36 9.54 20.79
Cost of Revenue
- - - - - - -
Gross Profit
82.03 152.31 166.80 206.00 12.36 9.54 20.79
Operating Expenses
158.29 247.98 245.00 193.82 215.21 81.06 46.30
Research & Development
112.21 195.16 192.13 147.75 173.76 57.85 33.64
Selling, General & Administrative
46.08 52.82 52.87 46.07 41.45 23.22 12.66
Other Operating Expenses
- - - - - - -
Operating Income
-76.26 -95.67 -78.21 12.18 -202.85 -71.52 -25.51
Non-Operating Income
-10.48 -14.72 -50.32 1.53 - - -
Interest Income
- - - - - - -
Interest Expense
- - - - - - -
Other Non-Op Income / Expense
10.10 15.20 16.59 -0.52 0.52 -0.26 -0.03
Income Before Tax
-65.78 81.05 -27.89 10.64 -203.67 -72.15 -25.99
Income Tax Expense
0.00 0.00 1.84 1.30 - - -
Non-Controlling Interest
- - - - - - -
Net Income
-65.78 -80.94 -29.73 9.35 -203.67 -72.15 -25.99
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Depreciation & Amortization
- - - - - - -
EBITDA
-73.24 -92.13 -75.21 13.70 -201.65 -70.64 -24.83
Earnings Per Share (Basic)
-2.40 -3.00 -1.12 0.35 - - -
Diluted EPS
-2.40 -3.00 -1.12 0.35 - - -
Weighted Average Shares
27.39 27.00 26.63 26.45 - - -
Diluted Weighted Avg Shares
27.39 27.00 26.63 27.09 - - -
Comprehensive Income
-65.78 -80.94 -29.73 9.35 -203.67 -72.15 -25.99